| Autor: |
Ussai S; Clinical Pharmacology and Toxicology, University of Cagliari, 09124 Cagliari, Italy., Pistis M; Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09124 Cagliari, Italy., Missoni E; Center for Research on Health and Social Care Management (CERGAS), Bocconi University, 20124 Milan, Italy.; Saluteglobale.it Associazione di Promozione Sociale, 25123 Brescia, Italy., Formenti B; Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy., Armocida B; Istituto Superiore di Sanità, Department of Cardiovascular, Endocrine-Metabolic Diseases and Ageing, 00161 Rome, Italy., Pedrazzi T; Department of Occupational Medicine, Hygiene, Toxicology and Occupational Prevention, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy., Castelli F; Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy., Monasta L; Clinical Epidemiology and Public Health Research Unit, Institute for Maternal and Child Health-IRCCS 'Burlo Garofolo', Trieste, Italy., Lauria B; G. Gulotta' Foundation, 50100 Florence, Italy., Mariani I; WHO Collaborating Centre, Institute for Maternal and Child Health-IRCCS 'Burlo Garofolo', 34137 Trieste, Italy. |
| Abstrakt: |
Since the early stage of the current pandemic, digital contact tracing (DCT) through mobile phone apps, called "Immuni", has been introduced to complement manual contact tracing in Italy. Until 31 December 2021, Immuni identified 44,880 COVID-19 cases, which corresponds to less than 1% of total COVID-19 cases reported in Italy in the same period (5,886,411). Overall, Immuni generated 143,956 notifications. Although the initial download of the Immuni app represented an early interest in the new tool, Immuni has had little adoption across the Italian population, and the recent increase in its download is likely to be related to the mandatory Green Pass certification for conducting most daily activities that can be obtained via the application. Therefore, Immuni failed as a support tool for the contact tracing system. Other European experiences seem to show similar limitations in the use of DTC, leaving open questions about its effectiveness, although in theory, contact tracing could allow useful means of "proximity tracking". |
